Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 30S ribosomal subunit A-site decoding region is a critical functional domain within the bacterial ribosome responsible for ensuring the fidelity of protein synthesis (PubMed: 11014182). Located primarily within the 16S ribosomal RNA (rRNA), this region facilitates the specific interaction between the mRNA codon and the cognate aminoacyl-tRNA anticodon (NCBI: NBK22554). During translation, the decoding center undergoes conformational changes, specifically the flipping out of conserved adenine residues (A1492 and A1493 in E. coli), to monitor the accuracy of base pairing (PubMed: 11136711). This site is a major target for several classes of antibiotics, most notably aminoglycosides and tetracyclines (StatPearls: NBK541077). Aminoglycosides bind to the A-site and stabilize the active conformation regardless of codon-anticodon complementarity, leading to the incorporation of incorrect amino acids (mistranslation) and bacterial cell death (PubMed: 10542187). Tetracyclines, conversely, physically block the A-site to prevent the entry of aminoacyl-tRNA, thereby halting protein elongation (PubMed: 11130715). Because the bacterial A-site differs structurally from the human mitochondrial and cytosolic ribosomes, it allows for selective toxicity, though clinical use is often limited by potential side effects like ototoxicity and nephrotoxicity (PubMed: 16272181).
Inhibition of bacterial protein synthesis by binding to the 16S rRNA within the 30S subunit; aminoglycosides induce mRNA misreading by stabilizing the flipped-out state of A1492 and A1493 (PubMed: 11136711), while tetracyclines sterically block the A-site to prevent aminoacyl-tRNA binding (PubMed: 11130715).
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 30S ribosomal subunit A-site decoding region (30S A-site).